BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Audo R, Daien C, Papon L, Lukas C, Vittecoq O, Hahne M, Combe B, Morel J. Osteoprotegerin and tumor necrosis factor-related apoptosis-inducing ligand as prognostic factors in rheumatoid arthritis: results from the ESPOIR cohort. Arthritis Res Ther 2015;17:193. [PMID: 26220665 DOI: 10.1186/s13075-015-0705-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Abu El-Asrar AM, Ahmad A, Alam K, Bittoun E, Siddiquei MM, Mohammad G, Mousa A, De Hertogh G, Opdenakker G. Unbalanced Vitreous Levels of Osteoprotegerin, RANKL, RANK, and TRAIL in Proliferative Diabetic Retinopathy. Ocul Immunol Inflamm 2018;26:1248-60. [PMID: 28914577 DOI: 10.1080/09273948.2017.1343855] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
2 Liu C, Zheng M, Zhang T, Fu R, Wang H, Wang T, Qi W, Shao Z. TRAIL in CD8+ T cells from patients with severe aplastic anemia. Int J Hematol 2017;106:490-9. [PMID: 28631177 DOI: 10.1007/s12185-017-2279-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
3 Gómez-Vaquero C, Martín I, Loza E, Carmona L, Ivorra J, Narváez JA, Hernández-Gañán J, Alía P, Narváez J. Effect of Osteoprotegerin and Dickkopf-Related Protein 1 on Radiological Progression in Tightly Controlled Rheumatoid Arthritis. PLoS One 2016;11:e0166691. [PMID: 27911913 DOI: 10.1371/journal.pone.0166691] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
4 Mert U, Sanlioglu AD. Intracellular localization of DR5 and related regulatory pathways as a mechanism of resistance to TRAIL in cancer. Cell Mol Life Sci 2017;74:245-55. [DOI: 10.1007/s00018-016-2321-z] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 3.5] [Reference Citation Analysis]
5 Tisato V, Gonelli A, Voltan R, Secchiero P, Zauli G. Clinical perspectives of TRAIL: insights into central nervous system disorders. Cell Mol Life Sci 2016;73:2017-27. [PMID: 26910728 DOI: 10.1007/s00018-016-2164-7] [Cited by in Crossref: 24] [Cited by in F6Publishing: 29] [Article Influence: 4.0] [Reference Citation Analysis]
6 van Steenbergen HW, van der Helm-van Mil AH. Osteoprotegerin as biomarker for persistence of rheumatoid arthritis. Rheumatology (Oxford) 2016;55:949-50. [PMID: 26647458 DOI: 10.1093/rheumatology/kev415] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]